Lv2
108 积分 2025-05-08 加入
Association of Time‐Varying Clearance of Nivolumab With Disease Dynamics and Its Implications on Exposure Response Analysis
2个月前
已完结
CD25: A potential tumor therapeutic target
3个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
3个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
3个月前
已完结
Interleukin-2: Biology, Design and Application
3个月前
已完结
Structure of the Quaternary Complex of Interleukin-2 with Its α, ß, and γ c Receptors
3个月前
已完结
The role of interleukin-2 during homeostasis and activation of the immune system
3个月前
已完结
The Drug-Dosing Conundrum in Oncology — When Less Is More
7个月前
已完结
Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022
7个月前
已完结
Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
7个月前
已完结
皖公网安备34019202002308
